BERRY is a home-grown research study investigating the role of Sambucol® Black Elderberry Original Liquid (Sambucus nigra) in the treatment, progression and reduction of symptoms in participants with Coronavirus 19. It was devised and developed within EKHUFT and has received National Ethics approval to start recruiting. The study is a collaboration with the manufacturer Pharmacare and is a randomised, single blinded study.
Previous studies have shown that administration of Sambucol® led to more rapid recovery from influenza symptoms. It is hoped that it may also be effective in the treatment of COVID-19 in terms of reducing duration of symptoms and potentially reducing progression to more severe disease
This is one of the many home-grown research studies being developed in EKHUFT to help treat patients and understand how ways of working have changed during the pandemic